Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer.

Nobumasa TamuraHidehito HorinouchiKatsutoshi SekineYuji MatsumotoShuji MurakamiYasushi GotoShintaro KandaYutaka FujiwaraNoboru YamamotoYuichiro Ohe

Published in: Thoracic cancer (2019)

Subsequent cytotoxic chemotherapy, especially immediately after nivolumab, has better treatment efficacy than that of regimens without ICI pretreatment.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
locally advanced
squamous cell carcinoma
radiation therapy
rectal cancer
smoking cessation